Pregnancy & Medications

What Causes Poor Neonatal Adaptation in Antidepressant-Exposed Infants?

It was back in 2005 when we first reported on studies which demonstrated an increased risk of “poor neonatal adaptation” in infants with prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants in late pregnancy. [...]

By |2024-03-25T08:32:20-04:00February 8th, 2017|Pregnancy & Medications|Comments Off on What Causes Poor Neonatal Adaptation in Antidepressant-Exposed Infants?

Minimal Effects of Prenatal SSRIs on Motor Development in Exposed Children

When we meet with women to discuss the reproductive safety of antidepressant medications, one of the most challenging and anxiety-provoking aspects of the consultation is the discussion we have regarding the long-term effects of prenatal [...]

By |2016-11-09T10:26:16-04:00November 9th, 2016|Pregnancy & Medications|Comments Off on Minimal Effects of Prenatal SSRIs on Motor Development in Exposed Children

Prenatal Antiepileptic Exposure Increases Risk for Malformations: Does High-Dose Folic Acid Reduce Risk?

The CDC, the U.S. Public Health Service, and the American College of Obstetricians and Gynecologists (ACOG) all recommend that every woman of reproductive age get 400 micrograms (400 mcg) or 0.4 milligrams of folic acid [...]

By |2016-10-24T09:32:36-04:00October 24th, 2016|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Prenatal Antiepileptic Exposure Increases Risk for Malformations: Does High-Dose Folic Acid Reduce Risk?

Prenatal SSRI Exposure and Speech/Language Disorders: Many Headlines, Little Risk

Last week, an article looking at the cognitive and motor development of children with prenatal exposure to antidepressants was published in JAMA Psychiatry.  Since that time, we have received a lot of questions regarding the [...]

By |2020-11-26T08:31:57-04:00October 21st, 2016|Pregnancy & Medications|Comments Off on Prenatal SSRI Exposure and Speech/Language Disorders: Many Headlines, Little Risk

Press Release: Potential Treatment Option for Women Deciding to Discontinue Antidepressants During Pregnancy

Massachusetts General Hospital Efficacy Study Centers on EnBrace HR™ SUNSET, LA (PRWEB) OCTOBER 18, 2016: JayMac Pharmaceuticals is sponsoring a study at Massachusetts General Hospital to assess the efficacy of a pre-and post-natal supplement, EnBrace [...]

By |2016-10-18T14:38:06-04:00October 18th, 2016|Pregnancy & Medications|Comments Off on Press Release: Potential Treatment Option for Women Deciding to Discontinue Antidepressants During Pregnancy
Go to Top